Angiotensin Receptors in Astrocytomas and Their Prognostic Implications
Author Information
Author(s): Arrieta O, Pineda-Olvera B, Guevara-Salazar P, Hernández-Pedro N, Morales-Espinosa D, Cerón-Lizarraga T L, González-De la Rosa C H, Rembao D, Segura-Pacheco B, Sotelo J
Primary Institution: Instituto Nacional de Cancerología (INCan)
Hypothesis
The expression of angiotensin II receptors AT1 and AT2 in astrocytomas is associated with poor prognosis.
Conclusion
The study found that the expression of AT1 and AT2 receptors is linked to high-grade malignancy and poor survival rates in patients with astrocytomas.
Supporting Evidence
- 52% of tumors expressed AT1 receptors, while 44% expressed AT2.
- 67% of high-grade astrocytomas were positive for AT1, compared to 10% of low-grade tumors.
- Patients with AT1-positive tumors had a lower survival rate than those with AT1-negative tumors.
Takeaway
This study shows that certain receptors in brain tumors can help doctors understand how serious the tumors are and how to treat them better.
Methodology
A prospective study analyzing tumor samples from patients with astrocytomas using RT-PCR and immunohistochemistry.
Limitations
The survival rates observed in this study differ from those reported in the literature, possibly due to differences in study design and treatment protocols.
Participant Demographics
Median age of patients was 47 years, with a mix of low-grade (28%) and high-grade (72%) astrocytomas.
Statistical Information
P-Value
P<0.001
Confidence Interval
95% CI, 43.3–60.4
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website